Positron emission tomography imaging of dopamine D2/3 receptors in the human cortex with [11C]FLB 457: Reproducibility studies
- 4 May 2010
- Vol. 65 (1), 35-40
- https://doi.org/10.1002/syn.20813
Abstract
In a recent PET study, we demonstrated the ability to measure amphetamine‐induced DA release in the human cortex with the relatively high affinity dopamine D2/3 radioligand [11C]FLB 457 (Narendran et al., [2009] Synapse 63:447–461). The aim of this study was to evaluate the reproducibility and reliability of [11C]FLB 457 in the same imaging paradigm we used to measure amphetamine‐induced DA transmission. Six healthy human subjects (three males/three females) were studied twice with [11C]FLB 457, once at baseline and again 3 h following the end of the baseline scan. D2/3 receptor binding parameters were estimated using a two‐tissue compartment kinetic analysis in the cortical regions of interest and cerebellum (reference region). The test–retest variability and intraclass correlation coefficient were assessed for distribution volume (VT), binding potential relative to plasma concentration (BPP), and binding potential relative to nondisplaceable uptake (BPND) of [11C]FLB 457. The test–retest variability of [11C]FLB 457 VT, BPP, and BPND were ≤15%, consistent with the published test–retest variability for this ligand in other brain regions (Sudo et al., [2001] Nucl Med Commun 22:1215–1221; Vilkman et al., [2000] Eur J Nucl Med 27:1666–1673). In addition, no significant decrease in [11C]FLB 457 BPND was observed in the second scan compared to the first one. This suggests that the contribution of carryover mass of [11C]FLB 457 to the measured reduction in [11C]FLB 457 BPND following amphetamine was relatively low. These data support the further validation of [11C]FLB 457 as a tool to measure amphetamine‐induced dopamine release in the human cortex. Synapse 65:35–40, 2011.Keywords
This publication has 21 references indexed in Scilit:
- HRRT Versus HR+ Human Brain PET Studies: An Interscanner Test–Retest StudyJournal of Nuclear Medicine, 2009
- Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallyprideSynapse, 2009
- Measurement of GABAA receptor binding in vivo with [11C]Flumazenil: A test–retest study in healthy subjectsNeuroImage, 2008
- Optimal Metabolite Curve Fitting for Kinetic Modeling of 11C-WAY-100635Journal of Nuclear Medicine, 2007
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding RadioligandsJournal of Cerebral Blood Flow & Metabolism, 2007
- Advances in functional and structural MR image analysis and implementation as FSLNeuroImage, 2004
- Measurement of Cortical Dopamine D1 Receptor Binding with [11C]SCH 23390: A Test–Retest AnalysisJournal of Cerebral Blood Flow & Metabolism, 2001
- Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithmIEEE Transactions on Medical Imaging, 2001
- Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PETNeuroImage, 1998
- A quantitative model for the in vivo assessment of drug binding sites with positron emission tomographyAnnals of Neurology, 1984